Old Web
English
Sign In
Acemap
>
authorDetail
>
Christopher Reggio
Christopher Reggio
New York Medical College
Obinutuzumab
CD20
Antibody-dependent cell-mediated cytotoxicity
Immunology
Medicine
4
Papers
5
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Rare Case of COVID-19 Related Necrotizing Myopathy
2021
Archives of Physical Medicine and Rehabilitation
Anish Paudel
Christopher Reggio
Anthony A. Donato
Kelly Crozier
Show All
Source
Cite
Save
Citations (0)
Necrotising myopathy and concurrent thyroiditis in a patient with COVID-19 infection.
2021
Case Reports
Christopher Reggio
Anish Paudel
Charles S. Specht
Anthony A. Donato
Show All
Source
Cite
Save
Citations (0)
A Comparative Global Phosphoproteomics Analysis of Obinutuzumab (GA101) Versus Rituximab (RTX) Against RTX Sensitive and Resistant Burkitt Lymphoma (BL) Demonstrates Differential Phosphorylation of Signaling Pathways Proteins
2014
Blood
Aradhana Awasthi
Delphine Rolland
Mona Elmacken
Christopher Reggio
Janet Ayello
Carmella van de Ven
Venkatesha Basrur
Kevin Conlon
Damian Fermin
Matthew J. Barth
Kojo S.J. Elenitoba-Johnson
Megan S. Lim
Mitchell S. Cairo
Show All
Source
Cite
Save
Citations (1)
Comparative Study of Obinutuzumab (GA101) Vs. Rituximab Against CD20+ rituximab-Sensitive and -Resistant Burkitt (BL) and Acute Lymphoblastic Leukemia (B-ALL): Potential Targeted Therapy in Patients with High Risk BL and Pre-B-ALL
2014
Blood
Aradhana Awasthi
Janet Ayello
Carmella van de Ven
Mona Elmacken
Christopher Reggio
Matthew J. Barth
Mitchell S. Cairo
Show All
Source
Cite
Save
Citations (4)
1